← Leaderboards
Debomoy K Lahiri
Indiana Univ-Purdue Univ At Indianapolis
$12,109,049
Attributed
$12,109,049
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,109,049 · 11
By mechanism
R01$7,922,387 · 3
R21$1,716,918 · 4
R56$1,257,487 · 2
P30$1,212,257 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Johnny J He$17,169,604
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseUntranslated RegionsPathway InteractionsProteinsBaseAmyloid Beta-ProteinBrainNerve DegenerationDementiaProtein PrecursorsLinkMediatingRegulationProductionEnzymesPeptidesElementsDepositionPropertyNeurodegenerative DisordersAmyloid ProteinsSamplingAmyloid
Grant awards (46)
Research Education Component$124,488
P30 · FY2025 · AG · contact PI
Research Education Component$125,598
P30 · FY2024 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$627,318
R56 · FY2023 · AG · contact PI
Research Education Component$200,485
P30 · FY2023 · AG · contact PI
Brain protein alteration by vascular overexpressed miRNA (BravomiR)$435,479
R21 · FY2022 · AG · contact PI
Alzheimer's disease-linked microRNA Exploration of UTR Polymorphisms (AdmiRE-UP)$435,349
R21 · FY2022 · AG · contact PI
Research Education Component$128,124
P30 · FY2022 · AG · contact PI
Role of microRNA in regulating Fe, Amyloid, and Tau (FeAT) in Alzheimer's disease$630,169
R56 · FY2021 · AG · contact PI
Research Education Component$129,444
P30 · FY2021 · AG · contact PI
Testing a Novel Approach to Solve the On-target, Off-site Effects of Alzheimer's Drugs$197,906
R21 · FY2020 · AG · contact PI
Research Education Component$171,032
P30 · FY2020 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$322,816
R01 · FY2019 · AG · contact PI
Testing a Novel Approach to Solve the On-target, Off-site Effects of Alzheimer's Drugs$237,531
R21 · FY2019 · AG · contact PI
Research Education Component$83,470
P30 · FY2019 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$322,816
R01 · FY2018 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$157,500
R01 · FY2018 · AG · contact PI
Research Education Component$83,470
P30 · FY2018 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$322,304
R01 · FY2017 · AG · contact PI
Research Education Component$83,470
P30 · FY2017 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$319,743
R01 · FY2016 · AG · contact PI
Administrative Supplement: Neurobiological role of MicroRNA in Alzheimer's$155,762
R01 · FY2016 · AG · contact PI
Research Education Component$82,676
P30 · FY2016 · AG · contact PI
Neurobiological Role of MicroRNA in Alzheimer's$319,743
R01 · FY2015 · AG · contact PI
Human MicroRNA as a potential therapeutic target in Alzheimer's disease.$182,449
R21 · FY2013 · AG · contact PI
Cholinesterase Inhibitors in Alzheimer's Disease$282,238
R01 · FY2012 · AG · contact PI
Human MicroRNA as a potential therapeutic target in Alzheimer's disease.$228,204
R21 · FY2012 · AG · contact PI
Cholinesterase Inhibitors in Alzheimer's Disease$278,893
R01 · FY2011 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$167,131
R01 · FY2011 · AG · contact PI
Cholinesterase Inhibitors in Alzheimer's Disease$290,151
R01 · FY2010 · AG · contact PI
Cholinesterase Inhibitors in Alzheimer's Disease$293,287
R01 · FY2009 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$287,640
R01 · FY2009 · AG · contact PI
Cholinesterase Inhibitors in Alzheimer's Disease$305,750
R01 · FY2008 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$287,640
R01 · FY2008 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$294,320
R01 · FY2007 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$297,771
R01 · FY2006 · AG · contact PI
Mechanisms of Cholinesterase Inhibitors on Beta-amyloid$282,267
R01 · FY2006 · AG · contact PI
Regulation of APP Pathway Gene Promoters in Alzheimer's$304,937
R01 · FY2005 · AG
Mechanisms of Cholinesterase Inhibitors on Beta-amyloid$289,060
R01 · FY2005 · AG
APP GENE PROMOTER IN ALZHEIMER'S DISEASE$298,000
R01 · FY2004 · AG
Mechanisms of Cholinesterase Inhibitors on Beta-amyloid$289,060
R01 · FY2004 · AG
APP GENE PROMOTER IN ALZHEIMER'S DISEASE$298,000
R01 · FY2003 · AG
Mechanisms of Cholinesterase Inhibitors on Beta-amyloid$289,060
R01 · FY2003 · AG
APP GENE PROMOTER IN ALZHEIMER'S DISEASE$298,000
R01 · FY2002 · AG
Mechanisms of Cholinesterase Inhibitors on Beta-amyloid$284,307
R01 · FY2002 · AG
APP GENE PROMOTER IN ALZHEIMER'S DISEASE$294,227
R01 · FY2001 · AG
APP GENE PROMOTER IN ALZHEIMER'S DISEASE$289,964
R01 · FY2000 · AG